Why the study?
Does combination therapy with antitachycardia pacemakers and automatic implantable cardioverter defibrillators effectively manage recurrent ventricular tachycardia in patients with drug-refractory pace-terminable sustained ventricular tachycardia?
Population
10 highly selected patients with drug-refractory pace-terminable sustained ventricular tachycardia
Design
Case_series
Follow-up
8 +/- 4.8 months
Authors
Loading...
Supports combined ATP-ICD use in selected refractory VT cases; leaves open need for prospective trials before broader adoption.
Does combination therapy with antitachycardia pacemakers and automatic implantable cardioverter defibrillators effectively manage recurrent ventricular tachycardia in patients with drug-refractory pace-terminable sustained ventricular tachycardia?
Combination therapy with antitachycardia pacemakers and automatic implantable cardioverter defibrillators can work synergistically to manage malignant ventricular arrhythmias in carefully selected patients.
Masterson et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: